4
Changes in Ownership
Nuvectis Pharma, Inc. Filed Acc 0001104659-22-063645
Chairman & CEO bought 1,200 shares at an average $16.73 ($20,070)
From the SEC's structured data for this filing
Trades in this filing
BENTSUR RON · Chairman & CEO
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2022-05-19 | Purchase : show line 1 in the form | +200 | $18.95 | $3,790 | 2,961,614 | D |
| 2022-05-20 | Purchase : show line 2 in the form | +1,000 | $16.28 | $16,280 | 2,962,614 | D |
| Open-market purchases · 1,200 sh · avg $16.73 · $20,070 | ||||||
Loading xslF345X03/tm2216562-2_4seq1.xml…